Congenital
Place your order for preplated version of libraries or request for customization and we configure the best screening set for your projects and inventory.
Write usProduct name
Size
Description
Download
9298 compounds
Lysine-specific histone demethylases (KDM) Library
26,000 compounds
Small‐molecule allosteric kinase modulators that target allosteric pockets of kinases outside the conserved ATP‐binding pocket.
40,000 compounds
Small-molecule compounds that can be used in GPCR drug discovery. Dysregulation of these receptors causes diabetes, CNS disorders.
20,000 compounds
microRNAs (miRs) are small (~18e25 nucleotides)
6,767 compounds
Set of RAR receptor antagonists. The retinoic acid receptor is a type of nuclear receptor which can also act as a transcription factor.
5,000 compounds
Glucocorticoid Receptors Library is small-molecule selective modulators of GR which regulates gene transcription.
3,055 compounds
Selective small-molecule PDZ inhibitors. They help to overcome drawbacks of PPI.
21,000 compounds
Epitranscriptome Focused Small Molecule Library modulates the activity of proteins involving in aberrant RNA modification.
25,883 compounds
Focused Epigenetics Library is a set of small-molecule modulators that target epigenetic proteins.
29,000 compounds
RNA Isosteric Trinucleotide Mimetics is small molecules targeting RNA expansion repeats. Trinucleotide repeats overexpression causes various disorders.
Tags
Custom ChemistryNovel Scaffolds and Discovery LibrariesCustom Building Blocks for DNA Encoded LibrariesScale up SynthesisMacrocycle CompoundsIn silico Drug Design (CADD)PROTACADME, DMPKMedicinal ChemistryDNA Encoded Libraries-CDI-CapabilitiesDiscovery BiologyAssay DevelopmentHigh Throughput Screening (HTS)Animal ModelsToxicology and SafetyChemistry, Manufacturing and ControlsPre-Plated SetRepresentative CompoundsNatural-Product3D-PharmacophoreMCE-18RepresentativeSoluble DiversityTargeted DiversitySmartTMAntiviralGPCR3DPhenotypic ScreeningCNS activityTranscription FactorsDrugs LibraryTarget ActivityTherapeutical DiversityCNSIon ChannelsProteases HumanKinases HumanPhosphatases HumanReceptors HumanOpportunistic PathogensCancerCardiovascularMetabolicImmune systemInfectionsMusculoskeletalDigestive systemRespiratory tractOtorhinolaryngologicNervous systemEyeMaleFemaleHemic and lymphaticCongenitalSkinEndocrineAnimalWoundsKinasesProteasesPhosphatasesNuclear receptorsOthersPPI modulatorsReceptor's ligandsEpigeneticMimeticsCyclic compoundsFragmentsPoolChemical classes AgroAllosteric Inhibitors